We examined Epstein-Barr virus (EBV)-specific antibodies in serum samples from 64 and 59 patients with EBV-positive and -negative gastric carcinomas, respectively, and 73 healthy controls using immunofluorescence assays. EBV capsid antigen (VCA) IgG and EBV-determined nuclear antigen (EBNA) IgG were
Mo1133 Anti-Viral Antibodies in Epstein-Barr Virus (EBV) Positive and Negative Gastric Cancer
✍ Scribed by Camargo, M. Constanza; Michel, Angelika; Kim, Kyoung-Mee; Matsuo, Keitaro; Liao, Linda M.; Torres, Javier; Zabaleta, Jovanny; Gulley, Margaret L.; Yatabe, Yasushi; Alvarado-Cabrero, Isabel; Lissowska, Jolanta; Kim, Sung; Pawlita, Michael; Rabkin, Charles S.
- Book ID
- 122303382
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 288 KB
- Volume
- 146
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Twenty‐one cases of gastric carcinoma were tested for the presence of Epstein‐Barr virus (EBV) genome by polymerase chain reaction (PCR) analysis. EBV genome was detected in 3 (14%) of the 21 cases. In situ hybridization for EBV‐encoded small RNA 1 showed that EBV genomes were present i
## Abstract Virus producing, VCA (viral capsid antigen)‐positive cells could be selectively removed from Epstein‐Barr virus (EBV)‐carrying, virus‐producer P3HR‐1 cultures by two different methods of column passage. In the first, the virus‐producing cells were covered with human EBV antibody and sub